UPDATED
Nov 20
New Users Please Click to Register
Renew or Upgrade your Existing  Account
UPDATE EMAIL
CHANGE PASSWORD
CHECK STATUS
CHECK PASSWORD

DISCLOSURE
BOOKMARK-HDCN
VBOOTHS
ABOUT OUR SITE
SYMPOSIA
FREE ZONE INDEX
ABSTRACTS
BY DATE
BY TOPIC
SEARCH HDCN
JOURNALS
SOCIETIES, LINKS
CLINICAL TRIALS
HYPERTENSION
DIALYSIS-CRF
CLIN NEPHROL
FREE ZONE
KEY ZONE
SEARCH

VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    ADC-2009(a)  :  ASDIN-2009(s/a/h)  :  RRI-2009(s/a/h)  :  ASN-2008(a)  :  NANT-2009(a)  :  ADC-2008(a)  :  Network9,10-2008(s/a/h)  :  RPA-2008(s/a/h)  :  ASDIN-2008(s/a/h)  :  RRI-2008(s/a/h)  :  ASN-2007(a)  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  

Rovin  

Anglicheau  

Joy  

  Personalized Therapy for Kidney Disease Flash slide/audio
(ASN Renal Week Clinical Nephrology Conference Extract, November, 2008)
Rovin: How can pharmacogenomics affect treatment of disease such as lupus nephritis? What alleles can affect metabolism of cyclophosphamide? Of azathioprine? Of MMF? How does Fc receptor polymorphism affect rituximab therapy? What can we learn from SELDI profiling of lupus flares? Can we use biomarkers to predict the progression of diabetic nephropathy? Anglicheau: What is the impact of gene polymorphisms affecting drug metabolizing enzymes on pharmacokinetics and dose requirements? On efficacy and drug activity? On ethnic differences in how drugs are handled? On drug safety assessment? What is the role of the MDR-1 gene which encodes P-glycoprotein? What about cytochrome P450_3A polymorphisms? How do CYP3A5*3 polymorphisms affect response to tacrolimus, sirolimus? How do TPMT polymorphisms affect azathioprine toxicity? Are ABCB1 polymorphisms associated with CsA nephrotoxicity? Joy: What is the effect of proteinuria on the pharmacokinetics of immunosuppressants? How do changes in serum albumin affect drug action? Which drugs are affected by loss into the urine with nephrotic syndrome? To what extent can failure of some immunosuppressive regimens in patients with nephrotic syndrome be explained via this mechanism?
(more...)


Hypertension, Cardiovascular
Anti-psychotic meds make kids fat
Revascularization of renal arteries no good
CKD, ESRD
TREAT trial of ESA in CKD diabetics
ESA cohort study in transplant patients
Alk phos increases death rate
Bioimpedance hydration in CKD5 longitudinally
Icodextrin RCT in PD
ECMO for severe ARDS in swine flu
Noninfected catheters still linked to inflammation
Hematide useful in pure red cell aplasia
Clinical Nephrology
Update on new kidney transplant allocation system
Interstitial cystitis review
Serum free light chain assessment
Rethinking mTOR inhibitors in Tx




Annual Dialysis Conference 2009
now in MP3
AUDIOFILE LIST (Annual Dialysis Conference 2009)
(17 talks)
Assisted PD
Dimitrios Oreopoulos, MD; Christian Verger, MD; Mat Oliver, MD; and Friedrich Prischl, MD

Improving Vascular Access Outcomes in HD
Leslie Dinwiddie, MSN, RN; Jack Work, MD; Carol Headley, DNSc, RN; Surendra Shenoy, MD; Arif Asif, MD; and Deborah Brouwer, RN

PD Catheter Damage: Risks, Realities, Repairs
Mary Zorzanello, MSN, RN

Psychological and Ethical Issues in Nephrology
Jean Holley, MD; and John Van Stone, MD


Hypertension, Cardiovascular:
Intact albumin gets reabsorbed from the tubule; ECF volume and sleep apnea; Fructose intake and high BP in NHANES; Podocyturia marks preeclampsia; BOLD imaging for ARVD; increasing diabetic CKD in African Americans.

Dialysis, CKD:
Systolic BP and mortality; More stroke on dialysis initiation; Chronic fluid overload vs. intradialytic weight gain; High transporters do better on APD; Dialysis units at risk under bundling; High-dose warfarin can hasten CKD progression; Glucose, insulin, HTN in MESA; Baroreflex activation therapy slows progression; Late start better; Vitamin D and ARB synergistically block diabetic nephropathy; MYH9 and CKD worldwide; NYH9 in AASK; Preventing catheter infection; Nasal carriage of MSRA and mortality; Hepcidin and anemia; Sickle cell train common in AA with ESRD; Lowering Pi suppresses vascular calcification genes; Fetuin-A and calcification; Duodenal signal for Pi excretion; Moderate CAC not associated with mortality in CKD; Progression of LVH in ESRD longitudinal study; Rosuvastatin good in ESRD diabetics; Nocturnal HD and VSCM biology; AV fistula linked to LVH; Vitamin D and ARB synergy in slowing LVH (rats)

Clinical Nephrology:
Nephrosclerosis of normal aging; GFR estimation from cystatin + creatinine; Low HCO3 and mortality in CKD; Chloride/base exchanger deletion causes distal RTA; NGAL in aute kidney injury; Combining urine and serum markers for AKI; Crescents come from parietal epithelial cells; Remote ischemic preconditioning protects against AKI after CABG; Anti-PLA2R antibodies and membranous; Rituximab, membranous GN and anti-PLA2R; Rituximab and phosphodiesterase 3b-precursor in FSGS; Scanning the genome in IGAN; Low-level donor-specific antibodies and rejection; de novo hyperglycemia post kidney Tx bad; combined urinary biomarkers predict DGF; mortality from cancer in US dialysis patients 1995-2005.  (more...)


    Hit reload / refresh
Login stopped working? Bouncing email logins suspended.
Slide/audio problem when lectures played with legacy options using Windows Media or Real Player.
HDCN_RSS  Click on RSS for details of each news story.
Updated: November 27, 2009 (Nov27)
Nov27 Zap your hands with ionized plasma to rid them of superbugs.
Nov27 Diabetes expected to double, costs to triple, by 2034 in the United States.
Nov26 Instead of looking to get omega-3s from fish, look to the algae.
Nov26 New theory of causation of multiple sclerosis focuses on iron injury due to impaired venous drainage.
Nov26 Rituximab helps preserve beta cell function in patients with early type 1 diabetes.
Nov25 Feeding time a major factor on gene induction circadian variability
Nov25 High salt intake linked to risk of stroke and cardiovascular disease.
Nov25 Nexilin mutations identified as a cause of dilated cardiomyopathy.
Nov25 Overweight? Try using smaller plates.
Nov24 Tech off-topic: What is clear type and how do you activate it on your computer?
Nov24 Tired of giving expensive vitamin Ds to dialysis patients? Cholecalciferol is cheap and seems to work.
Nov24 Diabetics show alarming increase in morbid obesity
Nov24 CDC issues prevalence maps by county for obesity and diabetes
Nov24 Paralyzed man was misdiagnosed as being in coma for 23 years.
Nov23 Progress in xenotransplant. Pig kidneys live for 50 days in baboons.
Nov23 Is there good Staph living in one's skin?
Nov21 HDCN: Pharmacogenetics, proteinuria pharma effects CNC; more ADC talks; RW09 abstracts
Nov20 CDC: Recs for clinical laboratories on how best to diagnose Shiga toxin-producing E.Coli.
Nov20 JASN: Removing a failed transplant associated with increased survival in ESRD patients.
Nov20 How to take a gorilla's blood pressure? Very carefully.
General Advances Emphasis
archive
Interstitial cystitis: an unsolved enigma
Moutzouris and Falagas review the diagnosis of IC, the role of specific and supportive therapies, and directions for future research, in the November issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

MASTering Treg function to promote tolerance
Levings and Thomson discuss a paper by Noelle in which rejection of skin grafts was treated by activation of mast cells in a T-cell mediated process; in the October issue of the Am J Transplant. (more...)

The Declaration of Istanbul: Review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee
Reed et al talk about the issues in applying the principles in this declaration to the North American setting; in the November issue of the Am J Transplant. (more...)

Encapsulating peritoneal sclerosis: Importance to the hemodialysis practitioner
In this Trainee Forum, Perl, Bargman and Chan tell us why peritoneal sclerosis is such an important issue to long-term PD and what we can do about it; in the October 2009 issue of the Hemodial Int (more...)

Mineralocorticoid receptor blockers and chronic kidney disease
Jain and colleagues review the scientific basis for renoprotection by blocking mineralocorticoid receptors, including a discussion of risks and benefits of current treatments; in the October issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

The Normal Hematocrit Cardiac Trial revisited
Goodin reviews previously unpublished aspects of this trial, including effects on platelets, mortality effects of Hb within groups, etc. in the Sept/Oct issue of Seminars in Dialysis. (more...)

Hepcidin for clinicians
Young and Zaritsky review the importance of hepciding in anemia management; in the August issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

A simple method to create buttonhole cannulation tracks in a busy hemodialysis unit
What's the secret? Marticorena and colleagues tell us how. in the August 2009 issue of the Hemodial Int (more...)

450+
  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

Boots on the Ground: Do We Have Enough Personnel to Fight the Battle Against CKD? (Wish and Piraino)
Controversies in Vascular Access (Asif and Urbanes)
ASDIN: 5th Annual Scientific Meeting, February, 2009.
Nephrology Quiz and Questionnaire: Fluids and Electrolyte and Glomerular Disorders (Palmer and Pusey)
Primary Care in Nephrology: Preoperative Risk Assessment and Management of Glycemic Control (Golper and Mordes)
IgA Nephropathy: Time to Change Our Approach? (Feehally and Hogg)
Advances in CKD 2009 (various speakers)
CKD Care and Your Practice Culture: Improve Your Performance! (Maddux, Molony, Kliger, Blaser, et al)
The Sexual Life Cycle of Women with CKD (Yao, Hou, Kurella-Tamura)
Resistant Hypertension: A Challenge for the Nephrologist (Campese and Steigerwalt)
New Frontiers in Phosphorus Homeostasis in CKD (Quarles, Wolf)
Care of the Chronic Kidney Disease Patient (Campbell, Berns, Batlle)
Managing CKD-MBD through the Disease Continuum (Thadhani, Kestenbaum)
Restoring Balance: New Therapeutic Approaches to Acute Decompensated Heart Failure (Goldberg, Schrier, and Gheorghiade)
The Year in Nephrology: Hypertension and Metabolic Renal Syndrome (Griffin and Beddhu)
Nephrology Roundtable: Glucose Transport and Targets for Intervention (De Zeeuw, Wright)
Acute Renal Replacement Therapy (Palevsky)
The ESA Controversy: The Role of Intravenous Iron (Ganz, Agarwal, Besarab)
Shades of Grey: Key Questions in the Future of Treatment for CKD-Related Anemia (Schmidt, Toto, Norris)
Gammopathies and the Kidney and Thrombotic Microangiopathy (Falk)
Ischemic Nephropathy: Diagnosis and Management (Textor)
Disorders of Calcium and Phosphorus Metabolism (Wolf)
FREE
Managing Anemia in Chronic Kidney Disease: The Benefits to Patients (Schira)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)
Nephrology Quiz and Questionnaire: Fluid and Electrolyte and Glomerulonephritis Cases (Emmett and Radhakrishnan)
Controversies in Diagnosis and Treatment of Atherosclerotic Renovascular Disease (Textor and Dworkin)
FREE
What You Can Teach Your Team About Chronic Kidney Disease-Related Mineral Bone Disorder (CKD-MBD) (Schmidt and Senft)
New Insights, Treatments, and Management Strategies for ADPKD (Chapman and Calvet)
FREE
Stabilizing Hemoglobin Levels: What's New in IV Iron and Anemia Management? (Fishbane, VanBuskirk, Larson)
Novel Therapeutics for Fluid and Electrolyte Disorders (Verbalis and Palmer)
DILEMMAS IN THE TREATMENT OF GLOMERULAR DISEASE:
Treatment of Frequently Relapsing/Steroid Dependent Minimal Change Disease (Hogg);
Evaluation and Treatment Approach to Steroid-Resistant Primary FSGS in Adults (Meyrier).
Congestive Heart Failure: A Nephrologist's Disease? (Murray)
AKI Therapeutics: From Bench to Commercialisation (Molitoris)
FREE
New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease (Qunibi, Szczech)
Renal Disease and the Metabolic Syndrome (Muntner and Fried)
Nephrolithiasis (Worcester and Lieske)
The Genetics of FSGS (Hildebrandt and Kaskel)
Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
Achieving Control: Optimizing the Management of CKD-Anemia (Nissenson, Fishbane, Germain, and Provenzano)
Mycophenolate in Lupus and Non-Glomerular Renal Diseases (Shaw and Appel)
  ASDIN Annual Meeting 2008
  RPA Annual Meeting 2008
  Advances in CKD 2008 (RRI 10th Annual International Dialysis Symposium
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 (Qunibi and Nolan)
Aldosterone: New Insights in Kidney Health and Disease (Calhoun and Rosenberg)
Pre-ESRD and Mineral Metabolism (Martin and Moe)
New Insights into Common Problems After Kidney Transplantation (Kasiske and Weisinger)
Challenges and Opportunities in the Treatment of Hyperuricemia and Gout (Terkeltaub, Rich, Feig)
New Treatments for Diabetes Mellitus: Implications for Clinicians (Nelson and Bakris)
The Aging Kidney (Fliser and Aronoff)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions (London, Langman, Ketteler)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction (Burnett, Fowler, Gheorghiade)
Cardiovascular Disease in End Stage Renal Disease Patients (Henrich)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis (Persson, Knopp, Perazella)
New Developments in Anemia Management in Chronic Kidney Disease (Roy, Besarab, Amerling, Berns)
The Cystic Diseases (Bennett)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia (Berns, Provenzano, Szczech)
Critical Care Nephrology (Murray)
FREE
Chronic Kidney Disease - Mineral Bone Disorder (Arruda, Snavely)
Electrolyte/Acid-Base Emergencies in the ICU (Palmer)
Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
FREE
Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions. A New Anemia Treatment Paradigm in Favor of the Patient (Easom, Juergensen, Amerling)
Sudden Death in Hemodialysis Patients: Epidemiology
Diabetes and Non-insulin Management in CKD
Obesity and Outcomes in Dialysis Patients
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
FREE
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease (Burrows-Hudson, Headley, Campoy)
FREE
Achieving and Maintaining a Phosphate Balance in the Patient With CKD (Mathers)
Cocaine and Chronic Kidney Injury
Proton Pump Inhibitors and the Kidney: Critical Review
Characteristics of the Long-Term Peritoneal Dialysis Patient
Prospects and Challenges for a Staphylococcal Vaccine
Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
Overview of Catheter Lock Solutions
Are ACE inhibitors and ARBs Essential to Renoprotection? Debate.
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease
3rd Annual Scientific Meeting of the ASDIN. April, 2007.
Improving Efficiency in the Nephrologist's Office. RPA Annual Meeting (2007)
RRI Ninth International Conference on Dialysis, January, 2007. Part Four
Bone and Mineral Metabolism in CKD: Medical Crossfire
RRI Ninth International Conference on Dialysis, January, 2007. Part Three
Fluid Dysregulation: Disturbances and Management
RRI Ninth International Conference on Dialysis, January, 2007. Part Two
Inflammation in CKD: Biomarkers, Morbidity and Therapy
Managing CMV Infections in Transplantation
RRI Ninth International Conference on Dialysis, January, 2007. Part One
Disorders of Sodium Metabolism: Case Presentations
The CKD that Follows Renal Transplantation: How to Best Manage these Patients?
Transplant Biopsy
The New KDOQI Guidelines for Anemia; Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Calcimimetics: Monotherapy for Secondary Hyperparathyroidism?
Lupus Nephritis: Defining and Treating Renal Flares
Secondary Hypertension, including Chronic Kidney Disease
New, Tri-Partite Approach to Anemia
Magnesium Balance: Hypomagnesemia and Hypermagnesemia
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
Transplantation: Medical and Immunosuppressive Management
  Using Technology to Improve the Quality of Care (target audience: technicians)
more...











 
Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

Warning-Disclaimer:
The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented in this journal/server.

Copyright statement:
Copyright - 1995 - 2008 by Medtext, Inc. All rights reserved. No part of the material on this journal/server may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher, except by a reviewer who may quote brief passages in a review.

Published by Medtext, Inc., Burr Ridge, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99